Scientists from UC San Francisco and Imperial College London have reported that a single high dose of psilocybin may physically and functionally reshape the brain for weeks after the psychedelic experience ends.
The findings, published in Nature Communications, add new evidence to the growing belief that psychedelic-assisted therapies may work not only through chemistry, but through measurable changes in brain organization, flexibility, and self-awareness. Researchers found that psilocybin increased “brain entropy,” a term used to describe a more diverse and less rigid pattern of neural activity.
Current Mental Health Treatments Often Leave Cognitive Rigidity Untouched
Traditional psychiatric treatments for depression and anxiety frequently focus on symptom reduction. While many medications can reduce emotional distress, they may not substantially alter the repetitive thought patterns and behavioral loops that keep people psychologically stuck.
Researchers behind the new study argue that psychedelic compounds may operate differently. Instead of simply dampening symptoms, psilocybin appears to temporarily loosen deeply established neural patterns, allowing the brain to reorganize itself in ways that may support long-term psychological change.
This concept is especially important in treatment-resistant conditions where patients often describe feeling trapped in fixed emotional states or repetitive internal narratives.
How Psilocybin Brain Plasticity Was Measured
The study involved 28 healthy adults with no history of psychedelic use. Participants first received a 1 mg dose of psilocybin that acted as a placebo comparison. Later, they received a 25 mg dose capable of producing a strong psychedelic experience.
Researchers monitored the participants using electroencephalography, functional MRI scans, and diffusion tensor imaging. These tools allowed scientists to examine both brain activity and the structural integrity of neural pathways before and after psilocybin exposure.
Within 60 minutes of taking the 25 mg dose, EEG recordings showed a major increase in brain entropy. Researchers interpreted this as evidence that the brain was processing information in a richer and more flexible way than usual.
Importantly, the people who experienced the largest increases in entropy were also the most likely to report strong psychological insight the following day.
Why Psychological Insight May Be Central To Recovery
One of the most striking conclusions from the study is that the psychedelic experience itself may not simply be a side effect of treatment. Instead, researchers believe the experience may be essential to therapeutic improvement.
Participants who described greater emotional insight after psilocybin also showed larger improvements in well-being several weeks later. The researchers suggest that entering a temporarily less rigid mental state may help individuals reconsider entrenched beliefs, emotional habits, and maladaptive thought patterns.
This idea aligns with broader theories in psychedelic psychiatry that emphasize flexibility, openness, and psychological revision as key mechanisms of healing.
The study’s senior author, Robin Carhart-Harris, described psychedelic experiences as moments that make the psyche more visible and accessible for examination.
Psilocybin Brain Plasticity May Extend Beyond Temporary Effects
Perhaps the most unexpected finding emerged one month after treatment. Brain imaging revealed denser and more organized neural tracts in participants who had received the higher dose of psilocybin.
Researchers noted that this pattern appears opposite to the neural diffusion often associated with aging and cognitive decline. While scientists caution that more research is needed, the findings suggest that psychedelic experiences could potentially influence physical brain organization in measurable ways.
Participants also demonstrated improvements in cognitive flexibility weeks after the experience. Cognitive flexibility refers to the brain’s ability to adapt, shift perspectives, and respond to changing situations effectively.
This combination of emotional insight, flexible thinking, and structural brain changes may help explain why psychedelic therapies are being explored for depression, addiction, post-traumatic stress disorder, and anxiety-related conditions.
What Makes This Research Especially Important
Many previous psychedelic studies focused primarily on symptom improvement. This study stands out because it combines subjective psychological reports with measurable brain imaging data across multiple time points.
The research also strengthens the growing scientific argument that psychedelic therapy should not be viewed solely as a pharmacological intervention. Instead, it may represent a neuroplasticity-driven therapeutic process involving biology, cognition, and emotional insight simultaneously.
While psilocybin remains under investigation and is not yet widely available as a standard psychiatric treatment, studies like this continue to reshape how clinicians think about recovery, resilience, and brain adaptability.
Citations
- Lyons T, et al. “Human Brain Changes After First Psilocybin Use.” Nature Communications. 2026.
https://www.nature.com/articles/s41467-026-71962-3 - Reuters. “Researchers Gain New Insight Into How Psychedelics Affect The Brain.” 2026.
https://www.reuters.com/business/healthcare-pharmaceuticals/researchers-gain-new-insight-into-how-psychedelics-affect-brain-2026-05-06/
Explore more at https://www.interventionalpsychiatry.org/